FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377019870> ?p ?o ?g. }

• W4377019870 endingPage "1082" @default.
• W4377019870 startingPage "1076" @default.
• W4377019870 abstract "²²⁵Ac-targeted α-radiotherapy is a promising approach to treating malignancies, including prostate cancer. However, α-emitting isotopes are difficult to image because of low administered activities and a low fraction of suitable γ-emissions. The in vivo generator ¹³⁴Ce/¹³⁴La has been proposed as a potential PET imaging surrogate for the therapeutic nuclides ²²⁵Ac and ²²⁷Th. In this report, we detail efficient radiolabeling methods using the ²²⁵Ac-chelators DOTA and MACROPA. These methods were applied to radiolabeling of prostate cancer imaging agents, including PSMA-617 and MACROPA-PEG₄-YS5, for evaluation of their in vivo pharmacokinetic characteristics and comparison to the corresponding ²²⁵Ac analogs. <b>Methods:</b> Radiolabeling was performed by mixing DOTA/MACROPA chelates with ¹³⁴Ce/¹³⁴La in NH₄OAc, pH 8.0, at room temperature, and radiochemical yields were monitored by radio–thin-layer chromatography. In vivo biodistributions of ¹³⁴Ce-DOTA/MACROPA.NH₂ complexes were assayed through dynamic small-animal PET/CT imaging and ex vivo biodistribution studies over 1 h in healthy C57BL/6 mice, compared with free ¹³⁴CeCl₃. In vivo, preclinical imaging of ¹³⁴Ce-PSMA-617 and ¹³⁴Ce-MACROPA-PEG₄-YS5 was performed on 22Rv1 tumor–bearing male nu/nu-mice. Ex vivo biodistribution was performed for ¹³⁴Ce/²²⁵Ac-MACROPA-PEG₄-YS5 conjugates. <b>Results:</b>¹³⁴Ce-MACROPA.NH₂ demonstrated near-quantitative labeling with 1:1 ligand-to-metal ratios at room temperature, whereas a 10:1 ligand-to-metal ratio and elevated temperatures were required for DOTA. Rapid urinary excretion and low liver and bone uptake were seen for ¹³⁴Ce/²²⁵Ac-DOTA/MACROPA. NH₂ conjugates in comparison to free ¹³⁴CeCl₃ confirmed high in vivo stability. An interesting observation during the radiolabeling of tumor-targeting vectors PSMA-617 and MACROPA-PEG₄-YS5—that the daughter ¹³⁴La was expelled from the chelate after the decay of parent ¹³⁴Ce—was confirmed through radio–thin-layer chromatography and reverse-phase high-performance liquid chromatography. Both conjugates, ¹³⁴Ce-PSMA-617 and ¹³⁴Ce-MACROPA-PEG₄-YS5, displayed tumor uptake in 22Rv1 tumor–bearing mice. The ex vivo biodistribution of ¹³⁴Ce-MACROPA.NH2, ¹³⁴Ce-DOTA and ¹³⁴Ce-MACROPA-PEG₄-YS5 corroborated well with the respective ²²⁵Ac-conjugates. <b>Conclusion:</b> These results demonstrate the PET imaging potential for ¹³⁴Ce/¹³⁴La-labeled small-molecule and antibody agents. The similar ²²⁵Ac and ¹³⁴Ce/¹³⁴La-chemical and pharmacokinetic characteristics suggest that the ¹³⁴Ce/¹³⁴La pair may act as a PET imaging surrogate for ²²⁵Ac-based radioligand therapies." @default.
• W4377019870 created "2023-05-19" @default.
• W4377019870 creator A5010028846 @default.
• W4377019870 creator A5014357212 @default.
• W4377019870 creator A5015860537 @default.
• W4377019870 creator A5016332122 @default.
• W4377019870 creator A5026285477 @default.
• W4377019870 creator A5035923646 @default.
• W4377019870 creator A5039268687 @default.
• W4377019870 creator A5044025712 @default.
• W4377019870 creator A5048826252 @default.
• W4377019870 creator A5070724003 @default.
• W4377019870 creator A5074856469 @default.
• W4377019870 creator A5078648367 @default.
• W4377019870 creator A5081788616 @default.
• W4377019870 creator A5091972324 @default.
• W4377019870 creator A5091972325 @default.
• W4377019870 date "2023-05-18" @default.
• W4377019870 modified "2023-10-14" @default.
• W4377019870 title "Evaluation of¹³⁴Ce/¹³⁴La as a PET Imaging Theranostic Pair for²²⁵Ac α-Radiotherapeutics" @default.
• W4377019870 cites W1788773500 @default.
• W4377019870 cites W1984398166 @default.
• W4377019870 cites W2003169578 @default.
• W4377019870 cites W2177595288 @default.
• W4377019870 cites W2256126127 @default.
• W4377019870 cites W2467018059 @default.
• W4377019870 cites W2566110194 @default.
• W4377019870 cites W2735823758 @default.
• W4377019870 cites W2757879990 @default.
• W4377019870 cites W2799908504 @default.
• W4377019870 cites W2889801464 @default.
• W4377019870 cites W2891647981 @default.
• W4377019870 cites W2892222776 @default.
• W4377019870 cites W2967856517 @default.
• W4377019870 cites W2999653667 @default.
• W4377019870 cites W3097405835 @default.
• W4377019870 cites W3112419202 @default.
• W4377019870 cites W3112621369 @default.
• W4377019870 cites W3131801237 @default.
• W4377019870 cites W3139391511 @default.
• W4377019870 cites W3148833394 @default.
• W4377019870 cites W3173952288 @default.
• W4377019870 cites W3174538298 @default.
• W4377019870 cites W3190387715 @default.
• W4377019870 cites W4220888112 @default.
• W4377019870 cites W4224234455 @default.
• W4377019870 cites W4224949026 @default.
• W4377019870 cites W4281252646 @default.
• W4377019870 cites W4283163361 @default.
• W4377019870 cites W4323971746 @default.
• W4377019870 cites W4324132617 @default.
• W4377019870 doi "https://doi.org/10.2967/jnumed.122.265355" @default.
• W4377019870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37201957" @default.
• W4377019870 hasPublicationYear "2023" @default.
• W4377019870 type Work @default.
• W4377019870 citedByCount "2" @default.
• W4377019870 countsByYear W43770198702023 @default.
• W4377019870 crossrefType "journal-article" @default.
• W4377019870 hasAuthorship W4377019870A5010028846 @default.
• W4377019870 hasAuthorship W4377019870A5014357212 @default.
• W4377019870 hasAuthorship W4377019870A5015860537 @default.
• W4377019870 hasAuthorship W4377019870A5016332122 @default.
• W4377019870 hasAuthorship W4377019870A5026285477 @default.
• W4377019870 hasAuthorship W4377019870A5035923646 @default.
• W4377019870 hasAuthorship W4377019870A5039268687 @default.
• W4377019870 hasAuthorship W4377019870A5044025712 @default.
• W4377019870 hasAuthorship W4377019870A5048826252 @default.
• W4377019870 hasAuthorship W4377019870A5070724003 @default.
• W4377019870 hasAuthorship W4377019870A5074856469 @default.
• W4377019870 hasAuthorship W4377019870A5078648367 @default.
• W4377019870 hasAuthorship W4377019870A5081788616 @default.
• W4377019870 hasAuthorship W4377019870A5091972324 @default.
• W4377019870 hasAuthorship W4377019870A5091972325 @default.
• W4377019870 hasBestOaLocation W43770198701 @default.
• W4377019870 hasConcept C150903083 @default.
• W4377019870 hasConcept C177322064 @default.
• W4377019870 hasConcept C178790620 @default.
• W4377019870 hasConcept C185592680 @default.
• W4377019870 hasConcept C197404232 @default.
• W4377019870 hasConcept C202751555 @default.
• W4377019870 hasConcept C207001950 @default.
• W4377019870 hasConcept C2777807558 @default.
• W4377019870 hasConcept C2779931791 @default.
• W4377019870 hasConcept C2989005 @default.
• W4377019870 hasConcept C55493867 @default.
• W4377019870 hasConcept C71924100 @default.
• W4377019870 hasConcept C86803240 @default.
• W4377019870 hasConceptScore W4377019870C150903083 @default.
• W4377019870 hasConceptScore W4377019870C177322064 @default.
• W4377019870 hasConceptScore W4377019870C178790620 @default.
• W4377019870 hasConceptScore W4377019870C185592680 @default.
• W4377019870 hasConceptScore W4377019870C197404232 @default.
• W4377019870 hasConceptScore W4377019870C202751555 @default.
• W4377019870 hasConceptScore W4377019870C207001950 @default.
• W4377019870 hasConceptScore W4377019870C2777807558 @default.
• W4377019870 hasConceptScore W4377019870C2779931791 @default.
• W4377019870 hasConceptScore W4377019870C2989005 @default.
• W4377019870 hasConceptScore W4377019870C55493867 @default.

• next